Macaques primed with self-amplifying RNA vaccines expressing HIV-1 envelope and boosted with recombinant protein show potent T- and B-cell responses

por Bogers, WM, Oostermeijer, H, Mooij, P, Koopman, G, Verschoor, E, Davis, D, Heeney, JL, Cu, Y, Banerjee, K, Burke, B, Dey, A, Geall, A, Barnett, SW
Publicado 2012

Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen

por Banerjee, K, Cu, Y, Sun, Y, Hartog, K, Dey, A, Brito, L, Verma, A, Nandi, A, Sarkar, P, Valiante, NM, Geall, AJ, Barnett, SW, Otten, GR
Publicado 2012

Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660

por Banerjee, K, Balsitis, S, Jamil, T, Jones, C, Dey, A, Flandez, J, Brito, L, Cu, Y, Beard, C, Santra, S, Pal, R, Miller, N, Valiante, NM, Mason, P, Barnett, SW, Otten, GR
Publicado 2012

Reinventing the nucleic acid vaccine with self-amplifying RNA

por Geall, AJ, Otten, GR, Hekele, A, Bogers, W, Oostermeijer, H, Mooij, P, Gerrit, K, Verschoor, E, Banerjee, K, Cu, Y, Beard, CW, Brito, LA, Ulmer, JB, Mandl, CW, Barnett, SW
Publicado 2012